Commit Biologics ApS. (2/14/24). "Press Release: Commit Biologics Receives Innobooster Grant from Innovation Fund Denmark Funding".

	Region	Denmark
	Organisation	InnovationsFonden (Innovation Fund Denmark, IFD)
	Group	Denmark (govt)
	Product	BiCE™ platform (Bispecific Complement Engaging platform)
	Product 2	business development (state/region)
	Index term	Commit Biologics–Denmark (govt): grant, 202402 Innobooster Grant DKK5m from Innovation Fund Denmark

Commit Biologics has received an Innobooster Grant of 5M DKK from the Innovation Fund Denmark (IFD) to support further development of the BiCE technology to fight cancer. This is the 2nd Innobooster Grant Commit Biologics receives from the Innovation Fund Denmark.

Read more about Innovation Fund Denmark.

Record changed: 2024-06-05

Picture biomindz TRON LSE Mainz Translation Cancer Immunotherapy 650x200px

More documents for Commit Biologics ApS

[1] Commit Biologics ApS. (5/9/24). "Press Release: Commit Biologics Launches with €16m Seed Financing to Pioneer Complement System Activation to Treat Cancer and Autoimmune Disease". Aarhus....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)